Michael Powell, Director at Orexigen Therapeutics, Inc. (OREX), sold 400,000 shares at $9.18 ($3.7M) on 2009-09-10, disclosed to the SEC on 2009-09-11.
Open-market sale of $3.7M OREX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.18 | 4,500 | $41K | 1.1% |
| 2 | $9.18 | 65,402 | $600K | 16.4% |
| 3 | $9.18 | 330,098 | $3.0M | 82.5% |
| Total | $9.18 avg | 400,000 | $3.7M | 100% |
| Filing → |
| OCRX | SELL | 2016-12-30 | $15K | — | Filing → |
| MIRN | BUY | 2015-10-06 | $6.0M | — | Filing → |
| AERI | SELL | 2014-07-11 | $24.2M | — | Filing → |